Skip to main content
Log in

Sulfated glycosaminoglycans in amyloid plaques of prion diseases

  • Regular Papers
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Summary

Brain sections from cases of human Creutzfeldt-Jakob disease, Gerstmann-Sträussler syndrome, kuru, and hamster scrapie containing amyloid were examined for the presence of sulfated glycosaminoglycans (GAGs), the anionic component of proteoglycans, using the sulfated Alcian blue method and Alcian blue technique with 0.3 M and 0.7 M magnesium chloride. These studies suggest that sulfated glycosaminoglycans are part of the CNS amyloid plaques in each of the above human prion disorders as well as in experimental scrapie. All the amyloid plaques stained positively with Alcian blue at 0.3 M, and less so at 0.7 M magnesium chloride indicating the presence of sulfated GAGs. Therefore, the amyloid plaques of prion diseases possess similar histochemical features to those found in Alzheimer's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Beck E, Daniel PM, Parry HB (1964) Degeneration of the cerebellar and hypothalamo-neurohypophysial systems in sheep with scrapie, and its relationship to human system degenerations. Brain 87:153–176

    Google Scholar 

  2. Bendheim PE, Barry RA, DeArmond SJ, Stites DP, Prusiner SB (1984) Antibodies to a scrapie prion protein. Nature 310:418–421

    Google Scholar 

  3. Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311

    Google Scholar 

  4. Bolton DC, Meyer RK, Prusiner SB (1985) Scrapie PrP 27-30 is a sialoglycoprotein. J Virol 53:596–606

    Google Scholar 

  5. Bruce M, Fraser M (1975) Amyloid plaques in the brains of mice infected with scrapie: morphological variation and staining properties. Neuropathol Appl Neurobiol 1:189–202

    Google Scholar 

  6. DeArmond SJ, McKinley MP, Barry RA, Braunfeld MB, McColloch JR, Prusiner SB (1985) Identification of prion amyloid filaments in scrapie-infected brain. Cell 41:221–235

    Google Scholar 

  7. DeArmond SJ, Mobley WC, DeMott DL, Barry RA, Beckstead JH, Prusiner SB (1987) Changes in the localization of brain prion proteins during scrapie infection. Neurology 37:1271–1280

    Google Scholar 

  8. Dorling J (1969) Critical electrolyte concentration method in histochemistry. J Med Lab Technol 26:124–130

    Google Scholar 

  9. Edwards RA, Woody RW (1979) Spectroscopic studies of Cibacron blue and Congo red bound to dehydrogenases and kinases. Evaluation of dyes as probes of the dinucleotide fold. Biochemistry 18:5197–5204

    Google Scholar 

  10. Gerstmann J, Sträussler E, Scheinker I (1936) Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol 154:736–762

    Google Scholar 

  11. Ihara Y, Abraham C, Selkoe DJ (1983) Antibodies to paired helical filaments in Alzheimer's disease do not recognize normal brain proteins. Nature 304:727–730

    Google Scholar 

  12. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331:530–532

    Google Scholar 

  13. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Methods in laboratory investigation; formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230–236

    Google Scholar 

  14. Klatzo I, Gajdusek DC, Zigas V (1959) Pathology of kuru. Lab Invest 9:799–847

    Google Scholar 

  15. Lendrum AC, Sidders W, Fraser S (1972) Renal hyalin: a study of amyloidosis and diabetic fibrinous vasculosis with new staining methods. J Clin Pathol 25:373–396

    Google Scholar 

  16. Marsh RF, Kimberlin RH (1975) Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology and pathogenesis. J Infect Dis 131:104–110

    Google Scholar 

  17. Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain 104:535–558

    Google Scholar 

  18. Masters CL, Gajdusek DC, Gibbs CJ Jr (1981) Creutzfeldt-Jakob disease virus isolations from the Gertmann-Sträussler syndrome: with analysis of various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104:559–588

    Google Scholar 

  19. Masters CL, Multhaup C, Simms C, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757–2763

    Google Scholar 

  20. McKinley MP, Bolton DC, Prusiner SB (1983) A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57–62

    Google Scholar 

  21. McLean IW, Nakane PK (1974) Periodate-lysine-paraformaldehyde fixative. A new fixative for immuno-electron microscopy. J Histochem Cytochem 22:1077–1083

    Google Scholar 

  22. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F, Cordell B (1988) A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331:525–527

    Google Scholar 

  23. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144

    Google Scholar 

  24. Prusiner SB (1987) Prions and neurodegenerative diseases. N Engl J Med 317:1571–1581

    Google Scholar 

  25. Prusiner SB, DeArmond SJ (1987) Biology of disease; prions causing nervous system denegeration. Lab Invest 56:349–363

    Google Scholar 

  26. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM (1980) Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 19:4883–4891

    Google Scholar 

  27. Prusiner SB, Cochran SP, Groth DF, Downey DE, Bowman KA, Martinez HM (1982) Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11:353–358

    Google Scholar 

  28. Puchtler H, Sweat F, Levine M (1962) On the binding of Congo red by amyloid. J Histochem Cytochem 10:355–364

    Google Scholar 

  29. Scott JE, Dorling J (1965) Differential staining of acid glycosaminoglycans (mucopolysaccharides) by Alcian blue in salt solutions. Histochemie 5:221–233

    Google Scholar 

  30. Snow AD, Kisilevsky R (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis: a histochemical study. Lab Invest 53:37–44

    Google Scholar 

  31. Snow AD, Kisilevsky R, Stephens C, Anastassiades T (1987) Characterization of tissue and plasma glyosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest 56:665–675

    Google Scholar 

  32. Snow AD, Willmer J, Kisilevsky R (1987) Sulphated glycosaminoglycans: a common constituent of all amyloids? Lab Invest 56:120–123

    Google Scholar 

  33. Snow AD, Willmer JP, Kisilevsky R (1987) Sulphated glycosaminoglycans in Alzheimer's disease. Hum Pathol 18:506–510

    Google Scholar 

  34. Snow AD, Mar H, Nochlin D, Wight TN (1988) Ultrastructural immunolocalization of heparan sulfate proteoglycans to amyloid fibrils in the neuritic plaques of Alzheimer's disease. J Neuropathol Exp Neurol 47:355 [abstr]

    Google Scholar 

  35. Stahl N, Borchelt DR, Hsiao K, Prusiner SB (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51:229–240

    Google Scholar 

  36. Szumanska G, Vorbrodt AW, Wisniewski HM (1986) Lectin histochemistry of scrapie amyloid plaques. Acta Neuropathol (Berl) 69:205–212

    Google Scholar 

  37. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve R (1988) Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331:528–530

    Google Scholar 

  38. Vorbrodt AW, Dobrogowska DH, Kim YS, Lossinsky AS, Wisniewski HM (1988) Ultrastructural studies of glycoconjugates in brain micro-blood vessels and amyloid plaques of scrapie-infected mice. Acta Neuropathol (Berl) 75:277–287

    Google Scholar 

  39. Willmer JP, Snow AD, Kisilevsky R (1986) The demonstration of sulfated glycosaminoglycans (GAGs) in association with the amyloidotic lesions of Alzheimer's disease. J Neuropathol Exp Neurol 45:340 [abstr]

    Google Scholar 

  40. Wisniewski HM, Bruce ME, Fraser H (1975) Infectious etiology of neuritic (senile) plaques in mice. Science 190:1108–1110

    Google Scholar 

  41. Wong CW, Quaranta V, Glenner GG (1985) Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related. Proc Natl Acad Sci USA 82: 8729–8732

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by Grant MT-3153 from the Medical Research Council of Canada, as well as research grants from the John Douglas French Foundation for Alzheimer's disease and the National Institutes of Health (NS22786, AG02132 and NS14069) and gifts from the R.J. Reynolds Industries, Sherman Fairchild Foundation, and Joseph and Stephaine Koret Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Snow, A.D., Kisilevsky, R., Willmer, J. et al. Sulfated glycosaminoglycans in amyloid plaques of prion diseases. Acta Neuropathol 77, 337–342 (1989). https://doi.org/10.1007/BF00687367

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00687367

Key words

Navigation